|
CN105256063A
|
|
Tumor marker DMBX1 and application thereof
|
|
CN105256064A
|
|
CSF2 gene and new application of expression product of CSF2 gene
|
|
CN105296658A
|
|
Application of ALKBH2 gene to diagnosis of cerebral ischemic stroke
|
|
CN105296659A
|
|
Gene marker related to ischemic stroke
|
|
CN105256062A
|
|
Micro RNA related to intracranial aneurysm
|
|
CN105296656A
|
|
Molecular marker for nasopharynx cancer diagnosis and treatment
|
|
CN105316417A
|
|
ZNRD1 gene and expression products thereof serving as diagnosis and treatment targets of intracranial aneurysm
|
|
CN105296657A
|
|
Intracranial aneurism diagnosis marker
|
|
CN105233290A
|
|
C22orf26 gene and application of expression product of C22orf26 gene to preparing Parkinson diagnosis and treatment preparation
|
|
CN105288659A
|
|
Application of TENM1 gene and its expression product on diagnosis and treatment of papillary adenocarcinoma
|
|
CN105200151A
|
|
Application of TCF21 gene as disease diagnosis marker
|
|
CN105296622A
|
|
LMNB2 gene and expression product thereof as diagnosing and treating target for nasopharyngeal carcinoma
|
|
CN105200150A
|
|
PLAC1 (placenta-specific 1) genes serving as diagnosis target of osteoarthritis
|
|
CN105256040A
|
|
Application of KHDC1L gene serving as disease diagnosis marker
|
|
CN105296623A
|
|
Molecular marker for diagnosis of osteoarthritis
|
|
CN105256039A
|
|
Osteoporosis diagnosis marker
|
|
CN105331691A
|
|
Application of PZP gene in diagnosis and treatment of biliary duct cancer
|
|
CN105331690A
|
|
Application of EPB41L4B gene in diagnosis and treatment of Parkinson disease
|
|
CN105087822A
|
|
Methylation clstn2 gene and application thereof
|
|
CN105219854A
|
|
The application of STK39 gene methylation site and diagnosis and treatment osteoarthritis thereof
|
